Barriers and facilitators for family physicians prescribing opioid agonist therapy in Saskatchewan

被引:0
|
作者
Nguyen, Teresa [1 ]
Bareham, Julia [2 ]
Halpape, Katelyn [3 ]
机构
[1] Loblaw Pharm Saskatoon, Saskatoon, SK, Canada
[2] Univ Saskatchewan, RxFiles Acad Detailing Program, Saskatoon, SK, Canada
[3] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada
关键词
COLLABORATIVE CARE; BUPRENORPHINE; EXPERIENCE; ABSTINENCE; ADDICTION; METHADONE;
D O I
10.46747/cfp.7004e52
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective To explore barriers and facilitators for family physicians in Saskatchewan prescribing opioid agonist therapy (OAT). Design Self-administered postal survey. Setting Family medicine practices in Saskatchewan. Participants A total of 218 Saskatchewan family physicians who were not authorized to prescribe OAT as of June 2022. Main outcome measures Descriptive and inferential statistics of physicians' self-reported barriers to and facilitators of prescribing OAT for opioid use disorder (OUD). Results Most respondents (84.8%) had some comfort with diagnosing OUD. However, more than half (58.3%) did not feel confident or knowledgeable about prescribing OAT. Barriers to OAT prescribing included lack of time, incomplete training requirements, lack of interest, insufficient funding or support, feeling overwhelmed, and perceiving that OAT does not work and thus is not necessary. Physicians working in core neighbourhoods and those receiving fee-for-service compensation reported the least available time to prescribe OAT. Conversely, physicians working in interdisciplinary team settings had increased time for OAT prescribing compared with physicians in other settings. Having a close personal relationship with someone with OUD was correlated with increased comfort in diagnosing OUD as well as with knowledge about and confidence in prescribing OAT. Themes identified as facilitators to increasing OAT prescribing included the addition of resources and supports, increased training, more awareness about OUD and OAT, enhanced compensation, and altered prescribing regulations. Conclusion Despite the presence of several real and perceived barriers limiting OAT prescribing by Saskatchewan family physicians, there are family physicians interested in providing this therapy. Increased clinical resources and support, including increased interdisciplinary practice, are actionable steps that should be considered by policy decision makers to address this issue. Additionally, increased OUD and OAT education, which includes the perspectives of those with lived experience of OUD, would help address physician confidence, knowledge, and awareness in this area.
引用
收藏
页码:e52 / e60
页数:9
相关论文
共 50 条
  • [41] Response to “understanding the behavioural determinants of opioid prescribing among family physicians: a qualitative study”
    Jason W. Busse
    David Juurlink
    D. Norman Buckley
    Gordon H. Guyatt
    BMC Family Practice, 21
  • [42] Response to "understanding the behavioural determinants of opioid prescribing among family physicians: a qualitative study"
    Busse, Jason W.
    Juurlink, David
    Buckley, D. Norman
    Guyatt, Gordon H.
    BMC FAMILY PRACTICE, 2020, 21 (01)
  • [43] Opioid Prescribing Practices and Training Needs of Quebec Family Physicians for Chronic Noncancer Pain
    Roy, Elise
    Cote, Richard J.
    Hamel, Denis
    Dube, Pierre-Andre
    Langlois, Eric
    Labesse, Maud Emmanuelle
    Thibault, Christiane
    Boulanger, Aline
    PAIN RESEARCH & MANAGEMENT, 2017, 2017
  • [44] Barriers and Facilitators to Injectable Opioid Agonist Treatment Engagement: A Qualitative Study of Patient Experiences in Vancouver, Canada
    Mayer, Samara
    Fairbairn, Nadia
    Fowler, Al
    Mcneil, Ryan
    DRUG AND ALCOHOL DEPENDENCE, 2025, 267
  • [45] A systematic review of qualitative evidence on barriers to and facilitators of the implementation of opioid agonist treatment (OAT) programmes in prisons
    Komalasari, Rita
    Wilson, Sarah
    Haw, Sally
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2021, 87
  • [46] Opioid Prescribing Patterns by Naturopathic Physicians in Oregon
    Bradley, Ryan
    Walter, Bill
    PAIN MEDICINE, 2019, 20 (02) : 414 - 415
  • [47] Barriers and facilitators to implement a service for pharmacists prescribing in Switzerland
    Amador-Fernandez, Noelia
    Matthey-de-l'Endroit, Julie
    Berger, Jerome
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (02) : 518 - 518
  • [48] Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians
    DeFlavio, J. R.
    Rolin, S. A.
    Nordstrom, B. R.
    Kazal, L. A., Jr.
    RURAL AND REMOTE HEALTH, 2015, 15 (01):
  • [49] Barriers and facilitators to prescribing medicinal cannabis in New Zealand
    Withanarachchie, Vinuli
    Rychert, Marta
    Wilkins, Chris
    JOURNAL OF PRIMARY HEALTH CARE, 2023, 15 (02) : 135 - 146
  • [50] Understanding Opioid Prescribing Practices of Resident Physicians
    Coughlin, Julia M.
    Terranella, Samantha L.
    Ritz, Ethan M.
    Xu, Thomas Q.
    Tierney, John F.
    Velasco, Jose M.
    Myers, Jonathan A.
    AMERICAN SURGEON, 2023, 89 (05) : 1554 - 1560